Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 305

1.

Is There a Role for MRI to Establish Treatment Indications and Effectively Monitor Response in Patients with Axial Spondyloarthritis?

Schwartzman M, Maksymowych WP.

Rheum Dis Clin North Am. 2019 Aug;45(3):341-358. doi: 10.1016/j.rdc.2019.04.009. Epub 2019 Jun 5. Review.

PMID:
31277748
2.

GRAPPA 2018 Project Report.

Goel N, FitzGerald O, Gladman DD, Helliwell PS, Kavanaugh A, Maksymowych WP, Mease PJ, Ritchlin CT, Coates LC.

J Rheumatol Suppl. 2019 Jun;95:54-57. doi: 10.3899/jrheum.190121.

PMID:
31154406
3.

Commentary on: reporting in axial spondyloarthritis: proposal for an MRI reporting system.

O'Neill J, Carmona R, Maksymowych WP.

Clin Radiol. 2019 May 22. pii: S0009-9260(19)30199-0. doi: 10.1016/j.crad.2019.04.011. [Epub ahead of print] No abstract available.

PMID:
31128852
4.

Drs. Lambert and Maksymowych reply.

Lambert RG, Maksymowych WP.

J Rheumatol. 2019 May;46(5):542. doi: 10.3899/jrheum.181215. No abstract available.

PMID:
31043501
5.

Biomarkers for Diagnosis of Axial Spondyloarthritis, Disease Activity, Prognosis, and Prediction of Response to Therapy.

Maksymowych WP.

Front Immunol. 2019 Mar 7;10:305. doi: 10.3389/fimmu.2019.00305. eCollection 2019. Review.

6.

Identification of fibrinogen as a natural inhibitor of MMP-2.

Sarker H, Hardy E, Haimour A, Maksymowych WP, Botto LD, Fernandez-Patron C.

Sci Rep. 2019 Mar 13;9(1):4340. doi: 10.1038/s41598-019-40983-y.

7.

A Fifty-Two-Week, Randomized, Placebo-Controlled Trial of Certolizumab Pegol in Nonradiographic Axial Spondyloarthritis.

Deodhar A, Gensler LS, Kay J, Maksymowych WP, Haroon N, Landewé R, Rudwaleit M, Hall S, Bauer L, Hoepken B, de Peyrecave N, Kilgallen B, van der Heijde D.

Arthritis Rheumatol. 2019 Jul;71(7):1101-1111. doi: 10.1002/art.40866. Epub 2019 May 28.

PMID:
30848558
8.

OMERACT Hip Inflammation Magnetic Resonance Imaging Scoring System (HIMRISS) Assessment in Longitudinal Study.

Jaremko JL, Lambert RGW, Pedersen SJ, Weber U, Lindsay D, Al-Ani Z, Steer K, Pianta M, Wichuk S, Maksymowych WP.

J Rheumatol. 2019 Feb 15. pii: jrheum.181043. doi: 10.3899/jrheum.181043. [Epub ahead of print]

PMID:
30770513
9.

Development and Validation of an OMERACT MRI Whole-Body Score for Inflammation in Peripheral Joints and Entheses in Inflammatory Arthritis (MRI-WIPE).

Krabbe S, Eshed I, Gandjbakhch F, Pedersen SJ, Bird P, Mathew AJ, Lambert RG, Maksymowych WP, Glinatsi D, Stoenoiu MS, Poggenborg R, Jans L, Jaremko JL, Herregods N, Foltz V, Conaghan PG, Althoff CE, Paschke J, Peterfy C, Hermann KA, Østergaard M; OMERACT MRI in Arthritis Working Group.

J Rheumatol. 2019 Feb 15. pii: jrheum.181084. doi: 10.3899/jrheum.181084. [Epub ahead of print]

PMID:
30770508
10.

Preliminary Definitions for Sacroiliac Joint Pathologies in the OMERACT Juvenile Idiopathic Arthritis Magnetic Resonance Imaging Score (OMERACT JAMRIS-SIJ).

Otobo TM, Conaghan PG, Maksymowych WP, van der Heijde D, Weiss P, Sudol-Szopinska I, Herregods N, Jaremko JL, Meyers AB, Rumsey D, Inarejos EC, Kirkhus E, Stimec J, Panwar J, Thorpe K, Jans L, van Rossum MA, Tolend M, Perez M, Tzaribachev N, Sandhya P, Tse S, Appenzeller S, Swami VG, Touma Z, Lambert R, Doria AS.

J Rheumatol. 2019 Feb 15. pii: jrheum.181115. doi: 10.3899/jrheum.181115. [Epub ahead of print]

PMID:
30770500
11.

The OMERACT MRI in Enthesitis Initiative: Definitions of Key Pathologies, Suggested MRI Sequences, and a Novel Heel Enthesitis Scoring System.

Mathew AJ, Krabbe S, Eshed I, Gandjbakhch F, Bird P, Pedersen SJ, Stoenoiu MS, Foltz V, Glinatsi D, Lambert RG, Hermann KGA, Maksymowych WP, Haugen IK, Jaremko JL, Poggenborg RP, Paschke J, Laredo JD, Carron P, Conaghan PG, Østergaard M.

J Rheumatol. 2019 Feb 1. pii: jrheum.181093. doi: 10.3899/jrheum.181093. [Epub ahead of print]

PMID:
30709961
12.

Comparative effectiveness of secukinumab and adalimumab in ankylosing spondylitis as assessed by matching-adjusted indirect comparison.

Maksymowych WP, Strand V, Nash P, Yazici Y, Thom H, Hunger M, Kalyvas C, Gandhi KK, Porter B, Jugl SM.

Eur J Rheumatol. 2018 Dec;5(4):216-223. doi: 10.5152/eurjrheum.2018.18162. Epub 2018 Oct 30.

13.

Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a randomised, placebo-controlled, phase 2 trial.

van der Heijde D, Baraliakos X, Gensler LS, Maksymowych WP, Tseluyko V, Nadashkevich O, Abi-Saab W, Tasset C, Meuleners L, Besuyen R, Hendrikx T, Mozaffarian N, Liu K, Greer JM, Deodhar A, Landewé R.

Lancet. 2018 Dec 1;392(10162):2378-2387. doi: 10.1016/S0140-6736(18)32463-2. Epub 2018 Oct 22.

14.

Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial.

van der Heijde D, Cheng-Chung Wei J, Dougados M, Mease P, Deodhar A, Maksymowych WP, Van den Bosch F, Sieper J, Tomita T, Landewé R, Zhao F, Krishnan E, Adams DH, Pangallo B, Carlier H; COAST-V study group.

Lancet. 2018 Dec 8;392(10163):2441-2451. doi: 10.1016/S0140-6736(18)31946-9. Epub 2018 Oct 22.

PMID:
30360964
15.

Beyond the TNF-α Inhibitors: New and Emerging Targeted Therapies for Patients with Axial Spondyloarthritis and their Relation to Pathophysiology.

Pedersen SJ, Maksymowych WP.

Drugs. 2018 Sep;78(14):1397-1418. doi: 10.1007/s40265-018-0971-x. Review.

PMID:
30171593
16.

Use of disease-modifying anti-rheumatic or anti-tumour necrosis factor drugs and risk of hospitalized infection in ankylosing spondylitis.

Moura CS, Rahme E, Maksymowych WP, Abrahamowicz M, Bessette L, Bernatsky S.

Scand J Rheumatol. 2019 Mar;48(2):121-127. doi: 10.1080/03009742.2018.1470253. Epub 2018 Aug 16.

PMID:
30112959
17.

Comparing Strategies Targeting Osteoporosis to Prevent Fractures After an Upper Extremity Fracture (C-STOP Trial): A Randomized Controlled Trial.

Majumdar SR, McAlister FA, Johnson JA, Rowe BH, Bellerose D, Hassan I, Lier DA, Li S, Maksymowych WP, Menon M, Russell AS, Wirzba B, Beaupre LA.

J Bone Miner Res. 2018 Dec;33(12):2114-2121. doi: 10.1002/jbmr.3557. Epub 2018 Aug 22.

PMID:
30040140
18.

Radiographs in screening for sacroiliitis in children: what is the value?

Weiss PF, Xiao R, Brandon TG, Biko DM, Maksymowych WP, Lambert RG, Jaremko JL, Chauvin NA.

Arthritis Res Ther. 2018 Jul 11;20(1):141. doi: 10.1186/s13075-018-1642-8.

19.

Feasibility and Reliability of the Spondyloarthritis Research Consortium of Canada Sacroiliac Joint Structural Score in Children.

Weiss PF, Maksymowych WP, Lambert RG, Jaremko JL, Biko DM, Paschke J, Brandon TG, Xiao R, Chauvin NA.

J Rheumatol. 2018 Oct;45(10):1411-1417. doi: 10.3899/jrheum.171329. Epub 2018 Jun 15.

PMID:
29907669
20.

Diffusion-weighted Imaging in Axial Spondyloarthritis: A Measure of Effusion or Does It Elicit Confusion?

Lambert RG, Maksymowych WP.

J Rheumatol. 2018 Jun;45(6):729-730. doi: 10.3899/jrheum.171479. No abstract available.

PMID:
29858453
21.

Options for Assessing Joints and Entheses in Psoriatic Arthritis by Ultrasonography and Magnetic Resonance Imaging: How to Move Forward.

Eder L, Aydin SZ, Kaeley GS, Maksymowych WP, Østergaard M.

J Rheumatol Suppl. 2018 Jun;94:44-47. doi: 10.3899/jrheum.180140.

PMID:
29858354
22.

Effectiveness, Complications, and Costs of Rheumatoid Arthritis Treatment with Biologics in Alberta: Experience of Indigenous and Non-indigenous Patients.

Barnabe C, Zheng Y, Ohinmaa A, Crane L, White T, Hemmelgarn B, Kaplan GG, Martin L, Maksymowych WP.

J Rheumatol. 2018 Oct;45(10):1344-1352. doi: 10.3899/jrheum.170779. Epub 2018 Jun 1.

PMID:
29858236
23.

Tofacitinib is associated with attainment of the minimally important reduction in axial magnetic resonance imaging inflammation in ankylosing spondylitis patients.

Maksymowych WP, van der Heijde D, Baraliakos X, Deodhar A, Sherlock SP, Li D, Fleishaker D, Hendrikx T, Kanik KS.

Rheumatology (Oxford). 2018 Aug 1;57(8):1390-1399. doi: 10.1093/rheumatology/key104.

24.

Clinical and MRI remission in patients with nonradiographic axial spondyloarthritis who received long-term open-label adalimumab treatment: 3-year results of the ABILITY-1 trial.

van der Heijde D, Sieper J, Maksymowych WP, Lambert RG, Chen S, Hojnik M, Anderson JK, Pangan AL.

Arthritis Res Ther. 2018 Mar 27;20(1):61. doi: 10.1186/s13075-018-1556-5.

25.

Feasibility and reliability of the Spondyloarthritis Research Consortium of Canada sacroiliac joint inflammation score in children.

Weiss PF, Maksymowych WP, Lambert RG, Jaremko JL, Biko DM, Paschke J, Brandon TG, Xiao R, Chauvin NA.

Arthritis Res Ther. 2018 Mar 22;20(1):56. doi: 10.1186/s13075-018-1543-x.

26.

Inflammatory and structural changes in vertebral bodies and posterior elements of the spine in axial spondyloarthritis: construct validity, responsiveness and discriminatory ability of the anatomy-based CANDEN scoring system in a randomised placebo-controlled trial.

Krabbe S, Sørensen IJ, Jensen B, Møller JM, Balding L, Madsen OR, Lambert RGW, Maksymowych WP, Pedersen SJ, Østergaard M.

RMD Open. 2018 Mar 16;4(1):e000624. doi: 10.1136/rmdopen-2017-000624. eCollection 2018.

27.

Patient-reported Outcomes, Resource Use, and Social Participation of Patients with Rheumatoid Arthritis Treated with Biologics in Alberta: Experience of Indigenous and Non-indigenous Patients.

Barnabe C, Crane L, White T, Hemmelgarn B, Kaplan GG, Martin L, Maksymowych WP.

J Rheumatol. 2018 Jun;45(6):760-765. doi: 10.3899/jrheum.170778. Epub 2018 Feb 15.

PMID:
29449496
28.

Spondyloarthritis: Low-dose CT for spondyloarthritis - a brilliant new chapter?

Maksymowych WP, Lambert RG.

Nat Rev Rheumatol. 2018 Mar;14(3):130-131. doi: 10.1038/nrrheum.2018.4. Epub 2018 Jan 25. No abstract available.

PMID:
29367690
29.

Limited radiographic progression and sustained reductions in MRI inflammation in patients with axial spondyloarthritis: 4-year imaging outcomes from the RAPID-axSpA phase III randomised trial.

van der Heijde D, Baraliakos X, Hermann KA, Landewé RBM, Machado PM, Maksymowych WP, Davies OR, de Peyrecave N, Hoepken B, Bauer L, Nurminen T, Braun J.

Ann Rheum Dis. 2018 May;77(5):699-705. doi: 10.1136/annrheumdis-2017-212377. Epub 2018 Jan 17.

30.

Sacroiliac Joint Magnetic Resonance Imaging in Asymptomatic Patients with Recurrent Acute Anterior Uveitis: A Proof-of-concept Study.

Oliveira TL, Maksymowych WP, Lambert RGW, Muccioli C, Fernandes ARC, Pinheiro MM.

J Rheumatol. 2017 Dec;44(12):1833-1840. doi: 10.3899/jrheum.170036. Epub 2017 Nov 1.

PMID:
29093157
31.

Evaluation of the change in structural radiographic sacroiliac joint damage after 2 years of etanercept therapy (EMBARK trial) in comparison to a contemporary control cohort (DESIR cohort) in recent onset axial spondyloarthritis.

Dougados M, Maksymowych WP, Landewé RBM, Moltó A, Claudepierre P, de Hooge M, Lambert RG, Bonin R, Bukowski JF, Jones HE, Logeart I, Pedersen R, Szumski A, Vlahos B, van der Heijde D.

Ann Rheum Dis. 2018 Feb;77(2):221-227. doi: 10.1136/annrheumdis-2017-212008. Epub 2017 Sep 29.

32.

Modification of structural lesions on MRI of the sacroiliac joints by etanercept in the EMBARK trial: a 12-week randomised placebo-controlled trial in patients with non-radiographic axial spondyloarthritis.

Maksymowych WP, Wichuk S, Dougados M, Jones HE, Pedersen R, Szumski A, Marshall L, Bukowski JF, Lambert RG.

Ann Rheum Dis. 2018 Jan;77(1):78-84. doi: 10.1136/annrheumdis-2017-211605. Epub 2017 Sep 29.

33.

Limited reliability of radiographic assessment of spinal progression in ankylosing spondylitis.

Aydin SZ, Kasapoglu Gunal E, Kurum E, Akar S, Mungan HE, Alibaz-Oner F, Lambert RG, Atagunduz P, Marzo Ortega H, McGonagle D, Maksymowych WP.

Rheumatology (Oxford). 2017 Dec 1;56(12):2162-2169. doi: 10.1093/rheumatology/kex321.

PMID:
28968836
34.

An update on biomarker discovery and use in axial spondyloarthritis.

Maksymowych WP.

Expert Rev Mol Diagn. 2017 Nov;17(11):965-974. doi: 10.1080/14737159.2017.1381562. Epub 2017 Sep 22. Review.

PMID:
28920498
35.

Hip Inflammation MRI Scoring System (HIMRISS) to predict response to hyaluronic acid injection in hip osteoarthritis.

Deseyne N, Conrozier T, Lellouche H, Maillet B, Weber U, Jaremko JL, Paschke J, Epstein J, Maksymowych WP, Loeuille D.

Joint Bone Spine. 2018 Jul;85(4):475-480. doi: 10.1016/j.jbspin.2017.08.004. Epub 2017 Sep 8.

PMID:
28893678
36.

Effect of certolizumab pegol over 96 weeks of treatment on inflammation of the spine and sacroiliac joints, as measured by MRI, and the association between clinical and MRI outcomes in patients with axial spondyloarthritis.

Braun J, Baraliakos X, Hermann KG, Landewé R, Machado PM, Maksymowych WP, Davies O, Hoepken B, Nurminen T, Stach C, van der Heijde D.

RMD Open. 2017 Apr 24;3(1):e000430. doi: 10.1136/rmdopen-2017-000430. eCollection 2017.

37.

Validation of a Knowledge Transfer Tool According to the OMERACT Filter: Does Web-based Real-time Iterative Calibration Enhance the Evaluation of Bone Marrow Lesions in Hip Osteoarthritis?

Jaremko JL, Azmat O, Lambert RGW, Bird P, Haugen IK, Jans L, Weber U, Winn N, Zubler V, Maksymowych WP.

J Rheumatol. 2017 Nov;44(11):1713-1717. doi: 10.3899/jrheum.161101. Epub 2017 Jul 1.

PMID:
28668804
38.

Whole-body Magnetic Resonance Imaging in Inflammatory Arthritis: Systematic Literature Review and First Steps Toward Standardization and an OMERACT Scoring System.

Østergaard M, Eshed I, Althoff CE, Poggenborg RP, Diekhoff T, Krabbe S, Weckbach S, Lambert RGW, Pedersen SJ, Maksymowych WP, Peterfy CG, Freeston J, Bird P, Conaghan PG, Hermann KG.

J Rheumatol. 2017 Nov;44(11):1699-1705. doi: 10.3899/jrheum.161114. Epub 2017 Jun 15. Review.

39.

MRI evidence of structural changes in the sacroiliac joints of patients with non-radiographic axial spondyloarthritis even in the absence of MRI inflammation.

Maksymowych WP, Wichuk S, Dougados M, Jones H, Szumski A, Bukowski JF, Marshall L, Lambert RG.

Arthritis Res Ther. 2017 Jun 6;19(1):126. doi: 10.1186/s13075-017-1342-9.

40.

Clinical effectiveness and safety of leflunomide in inflammatory arthritis: a report from the RAPPORT database with supporting patient survey.

Schultz M, Keeling SO, Katz SJ, Maksymowych WP, Eurich DT, Hall JJ.

Clin Rheumatol. 2017 Jul;36(7):1471-1478. doi: 10.1007/s10067-017-3687-5. Epub 2017 May 27.

PMID:
28550389
41.

Sustained efficacy, safety and patient-reported outcomes of certolizumab pegol in axial spondyloarthritis: 4-year outcomes from RAPID-axSpA.

van der Heijde D, Dougados M, Landewé R, Sieper J, Maksymowych WP, Rudwaleit M, Van den Bosch F, Braun J, Mease PJ, Kivitz AJ, Walsh J, Davies O, Bauer L, Hoepken B, Peterson L, Deodhar A.

Rheumatology (Oxford). 2017 Sep 1;56(9):1498-1509. doi: 10.1093/rheumatology/kex174.

42.

Effects of Long-Term Etanercept Treatment on Clinical Outcomes and Objective Signs of Inflammation in Early Nonradiographic Axial Spondyloarthritis: 104-Week Results From a Randomized, Placebo-Controlled Study.

Dougados M, van der Heijde D, Sieper J, Braun J, Citera G, Lenaerts J, van den Bosch F, Wei JC, Pedersen R, Bonin R, Jones H, Marshall L, Logeart I, Vlahos B, Bukowski JF, Maksymowych WP.

Arthritis Care Res (Hoboken). 2017 Oct;69(10):1590-1598. doi: 10.1002/acr.23276. Epub 2017 Aug 31.

43.

Fat metaplasia on MRI of the sacroiliac joints increases the propensity for disease progression in the spine of patients with spondyloarthritis.

Maksymowych WP, Wichuk S, Chiowchanwisawakit P, Lambert RG, Pedersen SJ.

RMD Open. 2017 Mar 30;3(1):e000399. doi: 10.1136/rmdopen-2016-000399. eCollection 2017.

44.

Proceedings of the GRAPPA 2016 Retreat.

Jadon DR, Gladman DD, Mease PJ, FitzGerald O, Chandran V, Goel N, Rosen CF, Maksymowych WP, Ritchlin CT, Ogdie A, Coates LC, Cauli A, Soriano ER, Husni ME, Campbell W, Azevedo VF, Callis Duffin K, Armstrong AW, Gottlieb AB, Kavanaugh A, Garg A, Helliwell PS.

J Rheumatol. 2017 May;44(5):668-673. doi: 10.3899/jrheum.170141.

PMID:
28461522
45.

Validation of a Knowledge Transfer Tool for the Knee Inflammation MRI Scoring System for Bone Marrow Lesions According to the OMERACT Filter: Data from the Osteoarthritis Initiative.

Jaremko JL, Azmat O, Lambert RG, Bird P, Haugen IK, Jans L, Weber U, Winn N, Zubler V, Maksymowych WP.

J Rheumatol. 2017 Nov;44(11):1718-1722. doi: 10.3899/jrheum.161102. Epub 2017 Apr 1.

PMID:
28365581
46.

Preliminary validation of the Knee Inflammation MRI Scoring System (KIMRISS) for grading bone marrow lesions in osteoarthritis of the knee: data from the Osteoarthritis Initiative.

Jaremko JL, Jeffery D, Buller M, Wichuk S, McDougall D, Lambert RG, Maksymowych WP.

RMD Open. 2017 Jan 18;3(1):e000355. doi: 10.1136/rmdopen-2016-000355. eCollection 2017.

47.

Patient-reported Flares in Ankylosing Spondylitis: A Cross-sectional Analysis of 234 Patients.

Jacquemin C, Maksymowych WP, Boonen A, Gossec L.

J Rheumatol. 2017 Apr;44(4):425-430. doi: 10.3899/jrheum.160838. Epub 2016 Dec 15.

PMID:
27980007
48.

Imaging in the diagnosis and management of axial spondyloarthritis.

Baraliakos X, Maksymowych WP.

Best Pract Res Clin Rheumatol. 2016 Aug;30(4):608-623. doi: 10.1016/j.berh.2016.09.011. Epub 2016 Nov 10. Review.

PMID:
27931957
49.

Measuring impairments of functioning and health in patients with axial spondyloarthritis by using the ASAS Health Index and the Environmental Item Set: translation and cross-cultural adaptation into 15 languages.

Kiltz U, van der Heijde D, Boonen A, Bautista-Molano W, Burgos-Vargas R, Chiowchanwisawakit P, Duruoz T, El-Zorkany B, Essers I, Gaydukova I, Géher P, Gossec L, Grazio S, Gu J, Khan MA, Kim TJ, Maksymowych WP, Marzo-Ortega H, Navarro-Compán V, Olivieri I, Patrikos D, Pimentel-Santos FM, Schirmer M, van den Bosch F, Weber U, Zochling J, Braun J.

RMD Open. 2016 Oct 4;2(2):e000311. eCollection 2016.

50.

Genetic diagnostic profiling in axial spondyloarthritis: a real world study.

Thomas GP, Willner D, Robinson PC, Cortes A, Duan R, Rudwaleit M, Akkoc N, Braun J, Chou CT, Maksymowych WP, Ozgocmen S, Roussou E, Sieper J, Valle-Oñate R, van der Heijde D, Wei J, Leo P, Brown MA; and the International Genetics of Ankylosing Spondylitis Consortium.

Clin Exp Rheumatol. 2017 Mar-Apr;35(2):229-233. Epub 2016 Oct 7.

PMID:
27749235

Supplemental Content

Loading ...
Support Center